{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:49:03Z","timestamp":1791841743273,"version":"4.3.4"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR204677"],"award-info":[{"award-number":["NIHR204677"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.vaccine.2025.128183","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T13:36:27Z","timestamp":1767101787000},"page":"128183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Enablers and barriers to participation in vaccine trials: a narrative synthesis"],"prefix":"10.1016","volume":"73","author":[{"given":"Nadia","family":"Daniel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasima","family":"Miah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Akroyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey","family":"Bingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monira Ahmed","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurdeep","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravinder","family":"Kundra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Prendergast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Chantkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Galiza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina","family":"Nakafero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Milton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena","family":"Mejia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atreya","family":"Ramanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deanna","family":"Rex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Owera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamlesh","family":"Khunti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saul N.","family":"Faust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maheshi N.","family":"Ramasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.128183_bb0005","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1080\/21645515.2019.1708669","article-title":"Why vaccines matter: understanding the broader health, economic, and child development benefits of routine vaccination","volume":"16","author":"Nandi","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2025.128183_bb0010","article-title":"Safety and efficacy of COVID-19 vaccines: a systematic review and meta-analysis of controlled and randomized clinical trials","volume":"34","author":"Beladiya","year":"2024","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.vaccine.2025.128183_bb0015","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1016\/S0140-6736(20)32466-1","article-title":"Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2\/3 trial","volume":"396","author":"Ramasamy","year":"2021","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.vaccine.2025.128183_bb0020","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1001\/jama.298.18.2155","article-title":"Vaccine-Preventable Disease Table Working Group and the Historical Comparisons of Morbidity and Mortality for Vaccine-Preventable Diseases in the United States","volume":"298","author":"Roush","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2025.128183_bb0025","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1016\/S2352-3018(23)00264-3","article-title":"Prophylactic HIV-1 vaccine trials: past, present, and future","volume":"11","author":"Nkolola","year":"2024","journal-title":"Lancet HIV"},{"key":"10.1016\/j.vaccine.2025.128183_bb0030","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.3390\/v16081337","article-title":"Update on hepatitis C vaccine: results and challenges","volume":"16","author":"Garbuglia","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2025.128183_bb0035","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4103\/picr.PICR_206_19","article-title":"Recruitment and retention of the participants in clinical trials: challenges and solutions","volume":"11","author":"Chaudhari","year":"2020","journal-title":"Perspect Clin Res"},{"key":"10.1016\/j.vaccine.2025.128183_bb0040","article-title":"Factors that impact on recruitment to vaccine trials in the context of a pandemic or epidemic: a qualitative evidence synthesis","volume":"9","author":"Meskell","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.vaccine.2025.128183_bb0045","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/14760584.2017.1297706","article-title":"Barriers and motivations to volunteers\u2019 participation in preventive vaccine trials: a systematic review","volume":"16","author":"Detoc","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2025.128183_bb0050","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1016\/j.vaccine.2017.06.003","article-title":"The complexity and cost of vaccine manufacturing \u2013 an overview","volume":"35","author":"Plotkin","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128183_bb0060","unstructured":"European Medicines Agency (EMA). ICH M3 (R2) Non-clinical safety studies for the conduct of human clinical trials for pharmaceuticals - Scientific guideline 2013. https:\/\/www.ema.europa.eu\/en\/ich-m3-r2-non-clinical-safety-studies-conduct-human-clinical-trials-pharmaceuticals-scientific-guideline (accessed August 5, 2025)."},{"key":"10.1016\/j.vaccine.2025.128183_bb0065","article-title":"IGHV1-69 polymorphism modulates anti-influenza antibody repertoires, correlates with IGHV utilization shifts and varies by ethnicity","volume":"6","author":"Avnir","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2025.128183_bb0070","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cels.2020.11.010","article-title":"Predicted cellular immunity population coverage gaps for SARS-CoV-2 subunit vaccines and their augmentation by compact peptide sets","volume":"12","author":"Liu","year":"2021","journal-title":"Cell Syst"},{"key":"10.1016\/j.vaccine.2025.128183_bb0075","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.3390\/vaccines11121784","article-title":"The challenges of vaccine trial participation among underserved and hard-to-reach communities: an internal expert consultation of the VACCELERATE consortium","volume":"11","author":"Poulimeneas","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2025.128183_bb0080","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s13063-020-4197-3","article-title":"Why do patients take part in research? An overview of systematic reviews of psychosocial barriers and facilitators","volume":"21","author":"Sheridan","year":"2020","journal-title":"Trials"},{"key":"10.1016\/j.vaccine.2025.128183_bb0085","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1186\/s13063-024-08670-0","article-title":"Factors that influence recruitment to COVID-19 vaccine trials: a qualitative evidence synthesis","volume":"25","author":"Biesty","year":"2024","journal-title":"Trials"},{"key":"10.1016\/j.vaccine.2025.128183_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.pec.2023.107861","article-title":"Why do people take part in vaccine trials? A mixed methods narrative synthesis","volume":"114","author":"Dean","year":"2023","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.vaccine.2025.128183_bb0095","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jclinepi.2020.10.007","article-title":"Cochrane Rapid Reviews Methods Group offers evidence-informed guidance to conduct rapid reviews","volume":"130","author":"Garritty","year":"2021","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.vaccine.2025.128183_bb0100","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1016\/j.vaccine.2024.03.053","article-title":"Perceptions, attitudes, and willingness of healthcare and frontline workers to participate in an Ebola vaccine trial in Uganda","volume":"42","author":"Kimbugwe","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128183_bb0105","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s12936-020-03293-7","article-title":"Caregiver and community perceptions and experiences participating in an infant malaria prevention trial of PfSPZ vaccine administered by direct venous inoculation: a qualitative study in Siaya County, western Kenya","volume":"19","author":"Achieng","year":"2020","journal-title":"Malar J"},{"key":"10.1016\/j.vaccine.2025.128183_bb0110","first-page":"22","article-title":"Motivations and concerns about adolescent tuberculosis vaccine trial participation in rural Uganda: a qualitative study","author":"Buregyeya","year":"2015","journal-title":"Pan Afr Med J"},{"key":"10.1016\/j.vaccine.2025.128183_bb0115","doi-asserted-by":"crossref","first-page":"7165","DOI":"10.1016\/j.vaccine.2019.09.094","article-title":"Factors influencing participation in an Ebola vaccine trial among front-line workers in Guinea","volume":"37","author":"Grantz","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128183_bb0120","doi-asserted-by":"crossref","first-page":"5850","DOI":"10.1016\/j.vaccine.2011.06.055","article-title":"Barriers of enrolment in HIV vaccine trials: a review of HIV vaccine preparedness studies","volume":"29","author":"Dhalla","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128183_bb0125","doi-asserted-by":"crossref","first-page":"6130","DOI":"10.1016\/j.vaccine.2011.06.064","article-title":"Selectively willing and conditionally able: HIV vaccine trial participation among women at \u201chigh risk\u201d of HIV infection","volume":"29","author":"Voytek","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128183_bb0130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.drugalcdep.2011.10.009","article-title":"Motivators and barriers influencing willingness to participate in candidate HCV vaccine trials: perspectives of people who inject drugs","volume":"123","author":"Park","year":"2012","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.vaccine.2025.128183_bb0135","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2072630","article-title":"Intention to participate in COVID-19 vaccine clinical trials in May 2021: a cross-sectional survey in the general French population","volume":"18","author":"Gagneux-Brunon","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2025.128183_bb0140","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1177\/1740774517722131","article-title":"Phase 1 healthy volunteer willingness to participate and enrollment preferences","volume":"14","author":"Chen","year":"2017","journal-title":"Clin Trials Lond Engl"},{"key":"10.1016\/j.vaccine.2025.128183_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0312799","article-title":"Understanding the barriers and enablers to participation in vaccine trials in a pregnant population from diverse ethnic background in an inner-city UK hospital","volume":"19","author":"Youssef","year":"2024","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2025.128183_bb0150","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1177\/1556264616679537","article-title":"Typologies of altruistic and financial motivations for research participation: a qualitative study of MSM in HIV vaccine trials","volume":"11","author":"Chin","year":"2016","journal-title":"J Empir Res Hum Res Ethics JERHRE"},{"key":"10.1016\/j.vaccine.2025.128183_bb0155","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10461-013-0519-8","article-title":"Motivators to participation in actual HIV vaccine trials","volume":"18","author":"Dhalla","year":"2014","journal-title":"AIDS Behav"},{"key":"10.1016\/j.vaccine.2025.128183_bb0160","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1016\/j.vaccine.2021.03.036","article-title":"The social experience of participation in a COVID-19 vaccine trial: subjects\u2019 motivations, others\u2019 concerns, and insights for vaccine promotion","volume":"39","author":"Wentzell","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128183_bb0165","doi-asserted-by":"crossref","first-page":"7002","DOI":"10.1016\/j.vaccine.2020.09.041","article-title":"Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic","volume":"38","author":"Detoc","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128183_bb0170","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/15562646221149818","article-title":"Jordanian undergraduate students\u2019 views of participation in clinical trials: the COVID-19 example","volume":"18","author":"Ahram","year":"2023","journal-title":"J Empir Res Hum Res Ethics"},{"key":"10.1016\/j.vaccine.2025.128183_bb0175","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/epirev\/mxac007","article-title":"Inclusionary trials: a review of lessons not learned","volume":"44","author":"Adkins-Jackson","year":"2022","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.vaccine.2025.128183_bb0180","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.4278\/ajhp.130125-QUAL-48","article-title":"African-American and Hispanic perceptions of HIV vaccine clinical research: a qualitative study","volume":"29","author":"Toledo","year":"2014","journal-title":"Am J Health Promot AJHP"},{"key":"10.1016\/j.vaccine.2025.128183_bb0185","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1089\/apc.2020.0008","article-title":"Exploring the engagement of racial and ethnic minorities in HIV treatment and vaccine clinical trials: a scoping review of literature and implications for future research","volume":"34","author":"Bass","year":"2020","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.vaccine.2025.128183_bb0190","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s13063-016-1291-7","article-title":"Engaging adolescents in tuberculosis and clinical trial research through drama","volume":"17","author":"Schmidt","year":"2016","journal-title":"Trials"},{"key":"10.1016\/j.vaccine.2025.128183_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051080","article-title":"Willingness to participate in HIV vaccine trials among men who have sex with men in Chennai and Mumbai, India: a social ecological approach","volume":"7","author":"Chakrapani","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2025.128183_bb0200","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1007\/s10900-017-0331-x","article-title":"Adolescent participation in HPV vaccine clinical trials: are parents willing?","volume":"42","author":"Erves","year":"2017","journal-title":"J Community Health"},{"key":"10.1016\/j.vaccine.2025.128183_bb0205","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1186\/1471-2458-13-1149","article-title":"Experiences on recruitment and retention of volunteers in the first HIV vaccine trial in Dar es Salam, Tanzania - the phase I\/II HIVIS 03 trial","volume":"13","author":"Bakari","year":"2013","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2025.128183_bb0210","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12874-017-0302-z","article-title":"Motivations for (non)participation in population-based health studies among the elderly \u2013 comparison of participants and nonparticipants of a prospective study on influenza vaccination","volume":"17","author":"Akmatov","year":"2017","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.vaccine.2025.128183_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.06.003","article-title":"Factors, motivations and barriers associated with eagerness to volunteer in COVID-19 vaccine clinical trials in France: a mixed-method study","volume":"42","author":"Helary","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128183_bb0220","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1186\/s12889-017-4355-z","article-title":"Using surrogate vaccines to assess feasibility and acceptability of future HIV vaccine trials in men: a randomised trial in inner-city Johannesburg, South Africa","volume":"17","author":"Chimoyi","year":"2017","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2025.128183_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0251992","article-title":"Willingness to participate in COVID-19 vaccine trials; a survey among a population of healthcare workers in Uganda","volume":"16","author":"Kitonsa","year":"2021","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2025.128183_bb0230","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1016\/j.vaccine.2022.04.003","article-title":"Factors associated with the intention to participate in COVID-19 vaccine clinical trials: a cross-sectional study in Peru","volume":"40","author":"De-Los-Rios-Pinto","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128183_bb0235","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1525\/jer.2010.5.2.65","article-title":"Vaccine trial consent preparedness among street drug users","volume":"5","author":"Fisher","year":"2010","journal-title":"J Empir Res Hum Res Ethics JERHRE"},{"key":"10.1016\/j.vaccine.2025.128183_bb0240","doi-asserted-by":"crossref","first-page":"905","DOI":"10.4161\/hv.20056","article-title":"Assessing the interest to participate in a dengue vaccine efficacy trial among residents of Puerto Rico","volume":"8","author":"Guerra","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2025.128183_bb0245","doi-asserted-by":"crossref","first-page":"6922","DOI":"10.1016\/j.vaccine.2020.08.059","article-title":"Pregnant women\u2019s perceptions of risks and benefits when considering participation in vaccine trials","volume":"38","author":"Jaffe","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128183_bb0250","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1016\/j.vaccine.2015.06.010","article-title":"Health benefit for the child and promotion of the common good were the two most important reasons for participation in the FinIP vaccine trial","volume":"33","author":"Nieminen","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128183_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014619","article-title":"Reasons for declining to enroll in a phase I and II HIV vaccine trial after randomization among eligible volunteers in Dar es Salaam, Tanzania","volume":"6","author":"Tarimo","year":"2011","journal-title":"PLOS ONE"},{"key":"10.1016\/j.vaccine.2025.128183_bb0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224831","article-title":"Perception of potential harm and benefits of HIV vaccine trial participation: a qualitative study from urban Tanzania","volume":"14","author":"Tarimo","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2025.128183_bb0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172661","article-title":"Prevalence of HPV 16 and 18 and attitudes toward HPV vaccination trials in patients with cervical cancer in Mali","volume":"12","author":"T\u00e9gu\u00e9t\u00e9","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2025.128183_bb0270","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.4161\/hv.28870","article-title":"Effect of race\/ethnicity on participation in HIV vaccine trials and comparison to other trials of biomedical prevention","volume":"10","author":"Dhalla","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2025.128183_bb0275","doi-asserted-by":"crossref","first-page":"8924","DOI":"10.1016\/j.vaccine.2011.09.067","article-title":"\u201cOnce I begin to participate, people will run away from me\u201d: understanding stigma as a barrier to HIV vaccine research participation in Kenya","volume":"29","author":"Nyblade","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128183_bb0280","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/1471-2458-10-292","article-title":"Balancing collective responsibility, individual opportunities and risks: a qualitative study on how police officers reason around volunteering in an HIV vaccine trial in Dar es Salaam, Tanzania","volume":"10","author":"Tarimo","year":"2010","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2025.128183_bb0285","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.drugpo.2009.04.004","article-title":"Using ethnographic fieldwork to inform hepatitis C vaccine preparedness studies with people who inject drugs","volume":"21","author":"Maher","year":"2010","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.vaccine.2025.128183_bb0290","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.3390\/ijerph15081743","article-title":"Willingness to participate in vaccine-related clinical trials among older adults","volume":"15","author":"Raheja","year":"2018","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.vaccine.2025.128183_bb0295","doi-asserted-by":"crossref","first-page":"420","DOI":"10.4161\/hv.22903","article-title":"Enhanced retention strategies and willingness to participate among hard-to-reach female sex workers in Barcelona for HIV prevention and vaccine trials","volume":"9","author":"Etcheverry","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2025.128183_bb0300","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1007\/s00228-022-03385-0","article-title":"Why not? Motivations for entering a volunteer register for clinical trials during the COVID-19 pandemic","volume":"78","author":"Russo","year":"2022","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.vaccine.2025.128183_bb0305","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/aogs.13288","article-title":"Antenatal vaccination against group B streptococcus: attitudes of pregnant women and healthcare professionals in the UK towards participation in clinical trials and routine implementation","volume":"97","author":"McQuaid","year":"2018","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.vaccine.2025.128183_bb0310","doi-asserted-by":"crossref","first-page":"6711","DOI":"10.1016\/j.vaccine.2018.09.042","article-title":"Pregnant women\u2019s attitudes toward Zika virus vaccine trial participation","volume":"36","author":"Goldfarb","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128183_bb0315","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1186\/s12884-024-06710-w","article-title":"Understanding willingness and barriers to participate in clinical trials during pregnancy and lactation: findings from a US study","volume":"24","author":"Jacobson","year":"2024","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.vaccine.2025.128183_bb0320","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMp2030033","article-title":"Trustworthiness before trust - Covid-19 vaccine trials and the black community","volume":"383","author":"Warren","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2025.128183_bb0325","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1007\/s40615-022-01466-5","article-title":"Motivators and barriers to COVID-19 research participation at the onset of the COVID-19 pandemic in black communities in the USA: an exploratory study","volume":"10","author":"Barre","year":"2023","journal-title":"J Racial Ethn Health Disparities"},{"key":"10.1016\/j.vaccine.2025.128183_bb0330","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.3390\/ijerph20054391","article-title":"Community health representatives as trusted sources for increasing representation of American Indian communities in clinical research","volume":"20","author":"Sabo","year":"2023","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.vaccine.2025.128183_bb0335","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/her\/cys013","article-title":"The Community Liaison Program: a health education pilot program to increase minority awareness of HIV and acceptance of HIV vaccine trials","volume":"27","author":"Kelley","year":"2012","journal-title":"Health Educ Res"},{"key":"10.1016\/j.vaccine.2025.128183_bb0340","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1080\/21645515.2020.1834325","article-title":"Factors associated with parents\u2019 willingness to enroll their children in trials for COVID-19 vaccination","volume":"17","author":"Goldman","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2025.128183_bb0345","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.vaccine.2015.01.049","article-title":"Adolescent decision making about participation in a hypothetical HIV vaccine trial","volume":"33","author":"Alexander","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128183_bb0350","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1186\/s12889-017-4395-4","article-title":"Contextualizing willingness to participate: recommendations for engagement, recruitment & enrolment of Kenyan MSM in future HIV prevention trials","volume":"17","author":"Doshi","year":"2017","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2025.128183_bb0355","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1007\/s10461-024-04334-x","article-title":"Interest in I-PrEP and willingness to participate in clinical trials among men and transfeminine persons who have sex with men in sub-Saharan Africa: quantitative and qualitative findings from HPTN 075","volume":"28","author":"Sandfort","year":"2024","journal-title":"AIDS Behav"},{"key":"10.1016\/j.vaccine.2025.128183_bb0360","doi-asserted-by":"crossref","first-page":"6494","DOI":"10.1016\/j.vaccine.2019.08.076","article-title":"Young men who have sex with men\u2019s awareness, acceptability, and willingness to participate in HIV vaccine trials: results from a nationwide online pilot study","volume":"37","author":"Connochie","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128183_bb0365","series-title":"International Ethical Guidelines for Health-related Research involving Humans","author":"Council for International Organizations of Medical Sciences (CIOMS)","year":"2016"},{"key":"10.1016\/j.vaccine.2025.128183_bb0370","first-page":"1","article-title":"Money, coercion, and undue inducement: a survey of attitudes about payments to research participants","volume":"34","author":"Largent","year":"2012","journal-title":"IRB"},{"key":"10.1016\/j.vaccine.2025.128183_bb0375","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/tmi.13281","article-title":"Clinical trials in low-resource settings: the perspectives of caregivers of paediatric participants from Uganda, Tanzania and Kenya","volume":"24","author":"van den Berg","year":"2019","journal-title":"Trop Med Int Health TM IH"},{"key":"10.1016\/j.vaccine.2025.128183_bb0380","first-page":"61","article-title":"Paying research participants: regulatory uncertainty, conceptual confusion, and a path forward","volume":"17","author":"Largent","year":"2017","journal-title":"Yale J Health Policy Law Ethics"},{"key":"10.1016\/j.vaccine.2025.128183_bb0385","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/vaccines9010016","article-title":"Confidence and receptivity for COVID-19 vaccines: a rapid systematic review","volume":"9","author":"Lin","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2025.128183_bb0390","doi-asserted-by":"crossref","DOI":"10.2196\/37367","article-title":"Misinformation about COVID-19 vaccines on social media: rapid review","volume":"24","author":"Skafle","year":"2022","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.vaccine.2025.128183_bb0395","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2409329121","article-title":"Susceptibility to online misinformation: a systematic meta-analysis of demographic and psychological factors","volume":"121","author":"Sultan","year":"2024","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2025.128183_bb0400","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0316969","article-title":"Fake news, misinformation, vaccine hesitancy and the role of community engagement in COVID-19 vaccine acceptance in Southern Ghana","volume":"20","author":"Kuatewo","year":"2025","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2025.128183_bb0405","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2024.1483367","article-title":"Leveraging digital tools to enhance diversity and inclusion in clinical trial recruitment","volume":"12","author":"Tomiwa","year":"2024","journal-title":"Front Public Health"},{"key":"10.1016\/j.vaccine.2025.128183_bb0410","first-page":"126","article-title":"Significance of the ontological\/utilitarian distinction among measures of individualism and collectivism","author":"Ja","year":"2023","journal-title":"Psychol Rep"},{"key":"10.1016\/j.vaccine.2025.128183_bb0415","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1745-6215-15-65","article-title":"Complex realities: community engagement for a paediatric randomized controlled malaria vaccine trial in Kilifi, Kenya","volume":"15","author":"Angwenyi","year":"2014","journal-title":"Trials"},{"key":"10.1016\/j.vaccine.2025.128183_bb0420","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.socscimed.2008.02.003","article-title":"Taking social relationships seriously: lessons learned from the informed consent practices of a vaccine trial on the Kenyan coast","volume":"67","author":"Gikonyo","year":"2008","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.vaccine.2025.128183_bb0425","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/jcop.22951","article-title":"A qualitative study of stakeholder and researcher perspectives of community engagement practices for HIV vaccine clinical trials in South Africa","volume":"51","author":"Dietrich","year":"2023","journal-title":"J Community Psychol"},{"key":"10.1016\/j.vaccine.2025.128183_bb0430","article-title":"A community-partnered approach for diversity in COVID-19 vaccine clinical trials","volume":"7","author":"Castellon-Lopez","year":"2022","journal-title":"J Clin Transl Sci"},{"key":"10.1016\/j.vaccine.2025.128183_bb0435","first-page":"20","article-title":"Historical trauma, health care distrust, and the legacy of Tuskegee: implications for nurse practitioner practice and research","author":"Dolan","year":"2024","journal-title":"J Nurse Pract"},{"key":"10.1016\/j.vaccine.2025.128183_bb0440","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050091","article-title":"Communicating the results of clinical research to participants: attitudes, practices, and future directions","volume":"5","author":"Shalowitz","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2025.128183_bb0445","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s11121-013-0371-0","article-title":"Exploring barriers and facilitators to participation of male-to-female transgender persons in preventive HIV vaccine clinical trials","volume":"15","author":"Andrasik","year":"2014","journal-title":"Prev Sci Off J Soc Prev Res"},{"key":"10.1016\/j.vaccine.2025.128183_bb0450","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.2105\/AJPH.2014.301893","article-title":"Sources of racial\/ethnic differences in awareness of HIV vaccine trials","volume":"104","author":"Arnold","year":"2014","journal-title":"Am J Public Health"},{"key":"10.1016\/j.vaccine.2025.128183_bb0455","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0260555","article-title":"Peer- and community-led responses to HIV: a scoping review","volume":"16","author":"Ayala","year":"2021","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2025.128183_bb0460","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1186\/s12909-023-04373-3","article-title":"LGBTQ+cultural competency training for health professionals: a systematic review","volume":"23","author":"Yu","year":"2023","journal-title":"BMC Med Educ"},{"key":"10.1016\/j.vaccine.2025.128183_bb0465","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1016\/S2352-3018(19)30343-1","article-title":"Stigma reduction interventions in people living with HIV to improve health-related quality of life","volume":"7","author":"Andersson","year":"2020","journal-title":"Lancet HIV"},{"key":"10.1016\/j.vaccine.2025.128183_bb0470","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12874-020-00955-7","article-title":"When piloting health services interventions, what predicts real world behaviours? A systematic concept mapping review","volume":"20","author":"Hayes","year":"2020","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.vaccine.2025.128183_bb0475","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.3390\/vaccines11071259","article-title":"A systematic review of behaviour change techniques within interventions to increase vaccine uptake among ethnic minority populations","volume":"11","author":"Ekezie","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2025.128183_bb0480","series-title":"Research Inclusion Strategy 2022-2027","year":"2022"},{"key":"10.1016\/j.vaccine.2025.128183_bb0485","author":"NISEC II"},{"key":"10.1016\/j.vaccine.2025.128183_bb0490","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2199656","article-title":"Impact of the COVID-19 pandemic on routine vaccine landscape: a global perspective","volume":"19","author":"Basu","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2025.128183_bb0495","author":"Gates Foundation"},{"key":"10.1016\/j.vaccine.2025.128183_bb0500","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/d41586-025-02612-9","article-title":"Cancelling mRNA studies is the highest irresponsibility","volume":"644","year":"2025","journal-title":"Nature"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25014811?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25014811?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T09:04:03Z","timestamp":1770282243000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25014811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":99,"alternative-id":["S0264410X25014811"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128183","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enablers and barriers to participation in vaccine trials: a narrative synthesis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128183","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128183"}}